JPH03130097A - Detection of nucleic acid and detection reagent - Google Patents
Detection of nucleic acid and detection reagentInfo
- Publication number
- JPH03130097A JPH03130097A JP22377389A JP22377389A JPH03130097A JP H03130097 A JPH03130097 A JP H03130097A JP 22377389 A JP22377389 A JP 22377389A JP 22377389 A JP22377389 A JP 22377389A JP H03130097 A JPH03130097 A JP H03130097A
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- stranded nucleic
- nucleic acids
- detection
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 147
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 147
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 146
- 238000001514 detection method Methods 0.000 title claims description 57
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 26
- 239000000126 substance Substances 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 37
- 102000004190 Enzymes Human genes 0.000 claims abstract description 33
- 108090000790 Enzymes Proteins 0.000 claims abstract description 33
- 238000009396 hybridization Methods 0.000 claims abstract description 10
- 238000002372 labelling Methods 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 5
- 230000000295 complement effect Effects 0.000 claims description 19
- 238000000354 decomposition reaction Methods 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 abstract 4
- 239000000523 sample Substances 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 27
- 239000002585 base Substances 0.000 description 19
- 239000012445 acidic reagent Substances 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 241000700605 Viruses Species 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 101710163270 Nuclease Proteins 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 230000000593 degrading effect Effects 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 230000002285 radioactive effect Effects 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 239000004793 Polystyrene Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- 229920002223 polystyrene Polymers 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 208000026350 Inborn Genetic disease Diseases 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000000376 autoradiography Methods 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920002477 rna polymer Polymers 0.000 description 2
- 241000894007 species Species 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- DOMSGNHHKOFONC-UHFFFAOYSA-N 4-(2,5-dioxopyrrolidin-1-yl)oxy-2,3-dihydroxy-4-oxobutanoic acid Chemical compound OC(=O)C(O)C(O)C(=O)ON1C(=O)CCC1=O DOMSGNHHKOFONC-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 241000701242 Adenoviridae Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 101100028791 Caenorhabditis elegans pbs-5 gene Proteins 0.000 description 1
- UNPLRYRWJLTVAE-UHFFFAOYSA-N Cloperastine hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 UNPLRYRWJLTVAE-UHFFFAOYSA-N 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 208000031220 Hemophilia Diseases 0.000 description 1
- 208000009292 Hemophilia A Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000598171 Human adenovirus sp. Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000016144 Ribonuclease 11 Human genes 0.000 description 1
- 108050004601 Ribonuclease 11 Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000589970 Spirochaetales Species 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- 206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 108700010877 adenoviridae proteins Proteins 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000000802 evaporation-induced self-assembly Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 201000001386 familial hypercholesterolemia Diseases 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108700020942 nucleic acid binding protein Proteins 0.000 description 1
- 102000044158 nucleic acid binding protein Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は核酸の検出法及び試薬に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to methods and reagents for detecting nucleic acids.
[従来の技術]
最近遺伝子工学の進歩に伴い、特定の塩基配列を持つ核
酸の検出を行なう頻度が増加している。[Prior Art] With recent advances in genetic engineering, the frequency of detecting nucleic acids having specific base sequences has increased.
従来の核酸の検出法は、核酸を制限酵素で切断し、寒天
或はポリアクリルアミドのゲルを用いた電気泳動で分画
し、これをニトロセルロース等の吸着膜に物理的又は電
気的に転写し、かかる転写物を一本鎖に変性して、放射
性同位元素で標識された一本鎖核酸と交雑させ、これを
オートラジオグラフィーにて検出する方法が知られてい
る。或は、核酸に対する抗体による免疫学的検出法等が
知られている。Conventional nucleic acid detection methods involve cutting nucleic acids with restriction enzymes, fractionating them by electrophoresis using agar or polyacrylamide gel, and physically or electrically transferring this to an adsorption membrane such as nitrocellulose. A known method is to denature such a transcript into a single strand, hybridize it with a single stranded nucleic acid labeled with a radioactive isotope, and detect this by autoradiography. Alternatively, immunological detection methods using antibodies against nucleic acids are known.
[発明が解決しようとする課題]
しかしながら従来の検出法は試料核酸の膜への吸着、ゲ
ルの調製、電気泳動、膜への転写及びオートラジオグラ
フィー等の操作が煩雑且つ時間がかかり、自動化に不適
であり、安全性の点でも問題がある。また核酸が生物種
に共通の構造を持っているため大変特異性が悪い。[Problems to be solved by the invention] However, conventional detection methods require complicated and time-consuming operations such as adsorption of sample nucleic acid onto a membrane, gel preparation, electrophoresis, transfer to a membrane, and autoradiography, and are difficult to automate. This is inappropriate and poses safety problems. Furthermore, since nucleic acids have a structure common to all biological species, specificity is very poor.
[課題を解決するための手段]
本発明者らは上記問題点に鑑みて、交雑させた核酸を極
めて特異的、迅速且つ安全に検出でき、自動化が可能な
方法及び試薬を開発すべく鋭意検討した結果、本発明に
到達した。すなわち本発明は一本鎖核酸と、試料中の相
補的な一本鎖核酸を交雑し、特定の核酸を検出する方法
において、交雑しなかった一本鎖核酸を除去し、交雑し
て二本鎖となった核酸を、標識物質で標識された結合性
物質、で検出することを特徴とする核酸の検出法並びに
交雑しなかった一本鎖核酸を除去する物質及び交雑して
二本鎖となった核酸と反応する、標識物質で標識された
結合性物質を含有してなる請求項1〜9項のいずれか記
載の検出法に使用される核酸の検出試薬である。[Means for Solving the Problems] In view of the above-mentioned problems, the present inventors have conducted intensive studies to develop methods and reagents that can detect hybridized nucleic acids extremely specifically, rapidly, and safely, and that can be automated. As a result, we have arrived at the present invention. That is, the present invention is a method for detecting a specific nucleic acid by hybridizing a single-stranded nucleic acid with a complementary single-stranded nucleic acid in a sample. A nucleic acid detection method characterized by detecting stranded nucleic acids with a binding substance labeled with a labeling substance, a substance for removing uncrossed single-stranded nucleic acids, and a double-stranded nucleic acid after hybridization. A nucleic acid detection reagent used in the detection method according to any one of claims 1 to 9, comprising a binding substance labeled with a labeling substance that reacts with the nucleic acid.
この明細書において使用する「核酸」なる語は一本鎖及
び二本鎖の両方を指すものとし、必要な場合はそのどち
らかを明記するものとする。またこの「核酸」なる語は
塩基数の大小は問わず、1以上の塩基数を有する核酸を
全て含むものとする。The term "nucleic acid" as used in this specification refers to both single-stranded and double-stranded acids, and one or the other will be specified if necessary. Furthermore, the term "nucleic acid" includes all nucleic acids having one or more bases, regardless of the number of bases.
更にここで使用した「核酸」の中には核酸の単位成分で
あるヌクレオチドが天然に存在するものの他人工的に修
飾されたものも含むものとする。Furthermore, "nucleic acid" as used herein includes naturally occurring nucleotides as well as those in which nucleotides, which are unit components of nucleic acids, are artificially modified.
また「一本鎖核酸」なる語は文字通り一本鎖核酸そのも
のと鎖長の異なる一本鎖核酸同士が交雑してできた一本
鎖核酸部分を含むものとする。Furthermore, the term "single-stranded nucleic acid" literally includes a single-stranded nucleic acid portion formed by hybridizing a single-stranded nucleic acid itself and single-stranded nucleic acids having different chain lengths.
本発明における一本鎖核酸としては測定しようとする特
定の核酸の塩基配列と相補の配列を持つ核酸が挙げられ
る。The single-stranded nucleic acid in the present invention includes a nucleic acid having a sequence complementary to the base sequence of a specific nucleic acid to be measured.
デオキシリボ核酸(DNA)の場合、天然の二本鎖核酸
を一本鎖に分離・精製してもよく、又化学的方法、即ち
アデニン、グアニン、シトシン及びチミンの4種のヌク
レオチドを順番に結合していく方法で合成してもよい。In the case of deoxyribonucleic acid (DNA), natural double-stranded nucleic acids can be separated and purified into single strands, or chemical methods can be used to sequentially link four nucleotides: adenine, guanine, cytosine and thymine. It may be synthesized in any way.
好ましくは純度及び大量生産が容易であることから化学
的方法での:A製である。Preferably, it is manufactured by chemical method: A because of its purity and ease of mass production.
又リボ核酸(RIIA)の場合は一本鎖核酸をそのまま
使用できる。In the case of ribonucleic acid (RIIA), single-stranded nucleic acid can be used as is.
一本鎖核酸の塩基数は、通常l〜10000であり、精
度及び感度の点で長い方が好ましいが、一定の塩基数、
例えば約5(1G塩基以上では余り変化がない。The number of bases in a single-stranded nucleic acid is usually 1 to 10,000, and a longer number is preferable in terms of accuracy and sensitivity, but a certain number of bases,
For example, there is not much change at approximately 5 (1G bases or more).
好ましくは相補鎖が認識でき、且つ精度及び感度を確保
できる5〜100塩基である。Preferably, the length is 5 to 100 bases, which allows recognition of complementary strands and ensures accuracy and sensitivity.
又、一本鎖核酸は溶液中においても使用されるが、予め
支持体に固定させて使用することが再現性及び簡便さの
点で好ましい。支持体としてはニトロセルロース、ポリ
エチレン、ポリプロピレン、ポリスチレン、ポリ塩化ビ
ニル、ナイロン、シリコーン、ポリウレタン、ポリフッ
化ビニリデン等の合成樹脂、磁性体又はガラス、シリカ
ゲル、ベントナイト等の無機材質が挙げられるがこれら
に限られるものではない。。好ましくは保持能力の点で
ニトロセルロース、ポリフッ化ビニリデン、ポリスチレ
ン、ナイロン又はガラスである。Furthermore, although single-stranded nucleic acids can be used in solution, it is preferable to use them after being immobilized on a support in advance from the viewpoint of reproducibility and simplicity. Examples of the support include, but are not limited to, synthetic resins such as nitrocellulose, polyethylene, polypropylene, polystyrene, polyvinyl chloride, nylon, silicone, polyurethane, and polyvinylidene fluoride, magnetic materials, or inorganic materials such as glass, silica gel, and bentonite. It's not something you can do. . Preferred are nitrocellulose, polyvinylidene fluoride, polystyrene, nylon, or glass in terms of retention capacity.
固定化方法としては物理吸着による方法及び化学結合に
よる方法が挙げられる。物理吸着による方法としては、
具体的には吸着させようとする一本鎖核酸を含む溶液(
例えば、10μg/+nlの核酸を含むリン酸緩衝液等
)を所定の支持体と接触させること゛が挙げられる。必
要に応じて、反応後吸着を、より強固なものにするため
に支持体を加8(例えば、80°CX 120分等)し
ても構わない。又一方、化学結合による方法としては、
具体的にはアジノ基やカルボキシル基のような官能基が
予め導入された支持体及び一本鎖核酸とを二官能性架橋
剤(例えば、グルタルアルデヒド等)又は二官能性活性
化剤(例えば、水溶性カルボジイミド、カルボジイミダ
ゾール、N−ヒドロキシサクシニミド、ビス(スルフォ
サクシニミヂル)サブストレート、ジスルフィドサクシ
ニミヂルタータレート等)により共有結合させる方法が
挙げられる。これらのうち好ましくは、一本鎖核酸の結
合強度及び安定性が高まること及びハイブリダイセーフ
8フ時の反応性が良くなることから化学結合による方法
である。Immobilization methods include physical adsorption methods and chemical bonding methods. As a method using physical adsorption,
Specifically, a solution containing the single-stranded nucleic acid to be adsorbed (
For example, contacting a predetermined support with a phosphate buffer solution containing 10 μg/+nl of nucleic acid, etc. can be mentioned. If necessary, a support may be added (for example, at 80° C. for 120 minutes) to make the adsorption stronger after the reaction. On the other hand, as a method using chemical bonding,
Specifically, a support into which a functional group such as an azino group or a carboxyl group has been introduced and a single-stranded nucleic acid are combined with a bifunctional crosslinking agent (e.g., glutaraldehyde, etc.) or a bifunctional activating agent (e.g., Examples include a method of covalent bonding using water-soluble carbodiimide, carbodiimidazole, N-hydroxysuccinimide, bis(sulfosuccinimidyl) substrate, disulfide succinimidyl tartrate, etc.). Among these methods, chemical bonding is preferred because it increases the binding strength and stability of single-stranded nucleic acids and improves the reactivity during hybridization.
又、共有結合に際して、支持体表面と一本鎖核酸の結合
部位(末端塩基)迄の距離はある程度保つ方がハイブリ
ダイゼータ3フ時の反応性が良好となり、結果的には感
度アップにつながることから好ましい。即ち、架橋剤又
は活性化剤を用いて支持体と一本鎖核酸を結合する場合
、支持体の表面及び一本鎖核酸の結合部位の少なくとも
いずれか一方に予め導入された官能基部分が、ある程度
の分子長(例えば、inn等)以上をもつように化合物
(例えば、炭素数3以上のポリメチレン基、炭素数4以
上のポリエーテル基等)が挿入されていることが好まし
い。Also, during covalent bonding, maintaining a certain distance between the support surface and the binding site (terminal base) of the single-stranded nucleic acid improves the reactivity during hybridization, which ultimately leads to increased sensitivity. Therefore, it is preferable. That is, when a support and a single-stranded nucleic acid are bonded using a crosslinking agent or an activating agent, a functional group moiety introduced in advance into at least one of the surface of the support and the binding site of the single-stranded nucleic acid, It is preferable that a compound (for example, a polymethylene group having 3 or more carbon atoms, a polyether group having 4 or more carbon atoms, etc.) is inserted so as to have a certain molecular length (for example, inn, etc.).
また、ここでいう一本鎖核酸の種類は一つの対象物を検
出するために一種類でもよく、また複数の対象物を同時
に検出するために二種類以上(例えば2〜30種)であ
ってもよい。例えば細菌、ウィルス、 リケッチア、原
虫、スピロヘータ等の外来性の病原性物質に起因する疾
病及び/又は核酸の塩基配列の変異、即ち塩基の置換、
挿入、欠落、転位等に起因する遺伝性疾病、に夫々特異
的な一本鎖核酸の中で任意の対象物を複数種選択するこ
とができる。さらに同一種の疾病であっても数種類の異
なる塩基配列が存在する場合、即ち細菌やウィルスの変
異株または上記の遺伝的疾病等もその対象物とすること
ができる。具体的には、病原性物質として赤痢菌、ジフ
テリア菌、ボツリヌス菌、サルモネラ菌等の細菌類、ア
デノウィルス科ヒトアデノウィルス種、オルトミクンウ
イルス科インフルエンザウィルス種、バボーバウイルス
科ヒトパピローマウィルス種等のウィルス類が、又遺伝
性疾病として家族性高コレステロール血症、■空高脂血
症、サラセミア、血友病、糖尿病、癌等が夫々挙げられ
るがこれらに限られるものではない。In addition, the type of single-stranded nucleic acid referred to here may be one type for detecting one target, or two or more types (for example, 2 to 30 types) for simultaneously detecting multiple targets. Good too. For example, diseases caused by foreign pathogenic substances such as bacteria, viruses, rickettsiae, protozoa, spirochetes, etc. and/or mutations in the base sequence of nucleic acids, that is, base substitutions,
It is possible to select a plurality of arbitrary targets among single-stranded nucleic acids that are specific to genetic diseases caused by insertions, deletions, rearrangements, and the like. Furthermore, even if the same species of disease has several different base sequences, mutant strains of bacteria or viruses or the above-mentioned genetic diseases can also be used as targets. Specifically, pathogenic substances include bacteria such as Shigella, Diphtheria, Clostridium botulinum, and Salmonella, viruses such as human adenovirus species of the Adenoviridae family, influenza virus species of the Ortomycunviridae family, and human papillomavirus species of the Babovaviridae family. However, hereditary diseases include, but are not limited to, familial hypercholesterolemia, empty hyperlipidemia, thalassemia, hemophilia, diabetes, and cancer.
試料中の相補的な一本鎖核酸において核酸としては天然
に存在する二本鎖核酸に関連し、微生物、ウィルス、魚
類、鳥類、植物、動物、特に噴孔動物(ヒトを含む)に
由来する核酸が挙げられる。Complementary single-stranded nucleic acids in a sample are related to naturally occurring double-stranded nucleic acids and are derived from microorganisms, viruses, fish, birds, plants, animals, especially blowhole animals (including humans) Examples include nucleic acids.
ウィルスには一本鎖核酸からなるウィルスと二本鎖核酸
からなるウィルスがあり、これらは混在していてもよく
、各々単独に存在していても良い。Viruses include viruses consisting of single-stranded nucleic acids and viruses consisting of double-stranded nucleic acids, and these may be mixed or each may exist independently.
ここで用いる試料には種々の検体が存在することから、
一本鎖核酸と相補的な核酸以外に相補的でない核酸も含
まれる。また相補的でない核酸以外は存在しない場合も
ある。Since there are various analytes in the sample used here,
In addition to nucleic acids that are complementary to single-stranded nucleic acids, non-complementary nucleic acids are also included. In addition, there are cases where non-complementary nucleic acids are not present.
これらの核酸は通常、細胞から抽出し、制限酵素(例え
ば、EcoRi、旧ndI[[、Pst I 、Bgl
I等)での化学的手段又は超音波等の物理的手段によ
って処理することで核酸を断片化する。制限酵素による
調製法は通常0−1.0M−NaClを含む100mM
−Trls緩衝液(pH7,5)に核酸試料0.1−1
00μg及び制限酵素0.1〜100unltsを加え
、20〜45°C,10〜120分で振盪することで行
うことができる。これらの方法は、例エバトム・マニア
チス著、モレキュラー・クローニング、コールド・スプ
リング・ハーバ−・ラボ ラ ト リ −(Tom
Manlatls 、MOLECULARCLONI
NG、Co1d Sprlng口arbor Labo
ratory) p104.1982に詳述しである。These nucleic acids are typically extracted from cells and treated with restriction enzymes (e.g. EcoRi, old ndI [[, Pst I, Bgl
Nucleic acids are fragmented by treatment with chemical means such as I) or physical means such as ultrasound. The preparation method using restriction enzymes is usually 100mM containing 0-1.0M NaCl.
- Nucleic acid sample 0.1-1 in Trls buffer (pH 7,5)
This can be done by adding 00 μg and 0.1 to 100 units of restriction enzyme and shaking at 20 to 45°C for 10 to 120 minutes. These methods are described, for example, by Evatom Maniatis, Molecular Cloning, Cold Spring Harbor Laboratory (Tom
Manlatls, MOLECULARCLONI
NG, Cold Sprlng Mouth Arbor Labo
p104.1982.
また天然の核酸の量が少ない場合には種々の核酸合成酵
素を用い、試験管内で予め核酸量を検出に耐える迄増幅
させておくこともできる。Furthermore, when the amount of natural nucleic acid is small, the amount of nucleic acid can be amplified in advance in a test tube using various nucleic acid synthases until it can be detected.
相補的な一本鎖核酸を調製する方法としては断片化され
た核酸を加熱またはアルカリで変性させることが挙げら
れる。具体的には加熱の場合は約60〜150°C1約
1〜30分、好ましくは約80〜100″C1約IQ〜
20分で、アルカリ変性の場合は水酸化ナトリウムを含
む水溶液等を適量添加し、常温で約1〜30分程度放置
し、最後に中性に戻す方法が挙げられるが、これらに限
定されるものではない。Methods for preparing complementary single-stranded nucleic acids include denaturing fragmented nucleic acids with heat or alkali. Specifically, in the case of heating, about 60-150°C1 about 1-30 minutes, preferably about 80-100"C1 about IQ ~
In the case of alkali denaturation in 20 minutes, methods include, but are not limited to, adding an appropriate amount of an aqueous solution containing sodium hydroxide, leaving it for about 1 to 30 minutes at room temperature, and finally returning to neutrality. isn't it.
交雑させる方法としては、上記試料と一本鎖核酸と屈合
し、通常25〜80°C程度で約109〜10時間、加
温振盪する方法が挙げられる。又、これらの方法は市販
されている試薬キット(ラピッド ハイブリダイゼーシ
ョン システム「マルチプライム」 アマ−ジャム・ジ
ャパン製)を用いて行なえば更に容易である。Examples of the hybridization method include a method in which the above-mentioned sample is mixed with a single-stranded nucleic acid, and the mixture is heated and shaken usually at about 25 to 80°C for about 109 to 10 hours. Moreover, these methods are easier if carried out using a commercially available reagent kit (Rapid Hybridization System "Multi Prime" manufactured by Amerjam Japan).
交雑しなかった核酸を除去する方法としては特異的に処
理が行われる必要があることから酵素によって消化分解
する方法が挙げられる。酵素としては一本鎖核酸に特異
的に作用する酵素、例えばニス1ヌクレース(Sl−N
tlCLEASE)、マグビーンヌクレース(MLIN
G BEAN NUCLEASE)、ピー1ヌクレ
ース(PI−NUCLEASE)、パル31ヌクレース
(BAL〜3l−NUCLEASE)、エキソヌクレー
スエ、■、■(EXONIICLEASE−I、III
、■)、デオキシリボヌクレースエ(DEOXYRIB
ONUCLEASE−I )、U ホ3Cクレー スH
(RIBONUCLEASE−11)等の一本鎖切断酵
素が挙げられる。好ましくは特異性の点でニス1ヌクレ
ース、マグビーンヌクレース、パル31ヌクレースであ
る。Methods for removing unhybridized nucleic acids include a method of digestion and decomposition with enzymes, since specific treatment is required. Examples of enzymes include enzymes that act specifically on single-stranded nucleic acids, such as Nis-1 nuclease (Sl-N
tlCLEASE), Magbean Nuclease (MLIN
G BEAN NUCLEASE), PI-NUCLEASE, PAL 31-NUCLEASE (BAL~3l-NUCLEASE), EXONUCLEASE, ■, ■ (EXONIICLEASE-I, III
, ■), deoxyribonuclease (DEOXYRIB)
ONUCLEASE-I), U Ho3Crace H
(RIBONUCLEASE-11) and other single-strand cleaving enzymes. Preferred are Nis 1 nuclease, Magbean nuclease, and Pal 31 nuclease in terms of specificity.
これらの酵素で分解させる方法としては通常、約xpg
〜!μgの交雑した核酸を含む試料に0.001〜10
00unltsの一本鎖切断酵素を加え、20〜50℃
、5〜120分振盪することによって容易に行うことが
できる。具体的にはトム・マニアチス著、モレキュラー
・クローニング、コールド・スプリング・ハーバ−・ラ
ボラトリ−(Ton+ ManjaHs 、lll0L
ECULARCLONING、Co1d Spring
Harbor Laboratory) p237.
1982に詳述されている。The method of decomposition using these enzymes usually uses approximately xpg
~! 0.001-10 for samples containing μg of hybridized nucleic acids.
Add 00unlts of single strand cutting enzyme, 20-50℃
This can be easily done by shaking for 5 to 120 minutes. Specifically, Tom Maniatis, Molecular Cloning, Cold Spring Harbor Laboratory (Ton+ ManjaHs, lll0L)
ECULAR CLONING, Co1d Spring
Harbor Laboratory) p237.
1982.
交雑した核酸と反応する結合性物質としては交雑物の分
子内、特に水素結合で結合した鏡開に特異的に取り込ま
れる物質、例えば臭化エチジウム、二沃化プロピジウム
等の化学試薬又は蛋白、例えば抗体、二本鎖核酸結合蛋
白等が挙げられる。好ましくは物質の安全性、生成した
化合物の安定性の点で蛋白で、特に好ましくは抗体であ
る。抗体は、実際の検出では交雑しなかった核酸は分解
処理で系外へ除去されることから、特に交雑物に対して
のみ反応する抗体である必要はない。抗体はポリクロー
ナル抗体でもモノクローナル抗体でもどちらでも構わな
い。Binding substances that react with the hybridized nucleic acids include substances that are specifically incorporated into molecules of the hybrid, especially by hydrogen bonding, such as chemical reagents such as ethidium bromide and propidium diiodide, or proteins, e.g. Examples include antibodies, double-stranded nucleic acid binding proteins, and the like. Proteins are preferred from the viewpoint of substance safety and stability of produced compounds, and antibodies are particularly preferred. In actual detection, nucleic acids that have not hybridized with each other are removed from the system through a decomposition process, so it is not necessary that the antibodies specifically react only to hybrids. The antibody may be either a polyclonal antibody or a monoclonal antibody.
これらの抗体は通常の方法で以て調製される。These antibodies are prepared using conventional methods.
例えば日本生化学金線「続生化学実験講座S−免疫生化
学研究法」1〜84、東京化学同人に記載の方法によっ
て行われる。For example, it is carried out by the method described in Nippon Biochemistry Kinsen, "Sekibiochemistry Experiment Course S-Immunobiochemistry Research Methods" 1-84, Tokyo Kagaku Doujin.
またこれらの抗体に標識される標識物質としては放射性
同位元素、蛍光物質、発光物質、酵素及びこれらを間接
的に結合しうる化合物からなる群より選ばれた物質が挙
げられる。具体的には放射性同位元素として[32p]
、[36Sコ、[3)1コ及び[+40]等、蛍光物質
としてフルオレセインインチオシアネート(FITC)
、テトラメチルローダミンインチオシアネート(RIT
C)、アクリジンオレンジ、フルオレセイン及びエチジ
ウムブロマイド等、発光物質としてルミノール及びルシ
フェリン等、酵素としてペルオキシダーゼ、アルカリフ
ォスファターゼ、β−ガラクトシダーゼ及びグルコース
オキシダーゼ等、そして間接的に結合し得る化合物とし
てビオチン(アビジンが結合し得る)及び抗体(抗原及
び2次抗体が結合し得る)等がそれぞれ挙げられるがこ
れらに限られるものではない。好ましくは安全性の点で
放射性同位元素を除く標識物質であ−
標識化の方法は、例えば日本生化学金線「続生化学実験
講座5−免疫生化学研究法J 102〜112、東京化
学同人に記載の方法で容易に行われる。Examples of the labeling substance that can be used to label these antibodies include substances selected from the group consisting of radioactive isotopes, fluorescent substances, luminescent substances, enzymes, and compounds that can indirectly bind these substances. Specifically, as a radioactive isotope [32p]
, [36S, [3)1, and [+40], fluorescein inthiocyanate (FITC) is used as a fluorescent substance.
, tetramethylrhodamine inthiocyanate (RIT)
C), acridine orange, fluorescein, and ethidium bromide, luminescent substances such as luminol and luciferin, enzymes such as peroxidase, alkaline phosphatase, β-galactosidase, and glucose oxidase, and compounds that can be indirectly bound to biotin (avidin is bound to Examples include, but are not limited to, antibodies (to which an antigen and a secondary antibody can be bound), etc. Preferably, from the viewpoint of safety, a labeling substance excluding radioactive isotopes is used.The labeling method is, for example, published by Nippon Seikagaku Kinsen, "Seki Biochemistry Experiment Course 5-Immuno Biochemistry Research Methods J 102-112, Tokyo Kagaku Doujin. It is easily carried out by the method described in .
核酸に対する結合性物質で検出する方法としては通常の
免疫測定法(エンザイムイムノアッセイまたはラジオイ
ムノアッセイ)と同様の方法が挙げられる。即ち交雑す
る核酸に対して予め標識された抗体で検出する方法、ま
たは核酸と結合した抗体に対する標識二次抗体で検出す
る方法等が挙げられる。例えば特願昭[13−211i
2479号、特願昭6328[1071号、特願平1−
0211i379号各公報に詳述された方法である。Methods for detection using substances that bind to nucleic acids include methods similar to ordinary immunoassays (enzyme immunoassays or radioimmunoassays). Namely, examples include a method of detecting a hybridizing nucleic acid with a pre-labeled antibody, a method of detecting with a labeled secondary antibody against an antibody bound to a nucleic acid, and the like. For example, Tokugansho [13-211i
No. 2479, Japanese Patent Application No. 6328 [1071, Japanese Patent Application No. 1999]
This is a method detailed in each publication of No. 0211i379.
本発明の検出試薬は必須構成成分以外に、この検出試薬
の使用を便ならしめるために、種々の補助剤を包含させ
ることができる。例えば、固体を溶解させる溶解剤、反
応途中で不用な構成成分を除去するための洗浄剤、標準
物質が酵素である場合には、その酵素活性を測定するた
めの基質及び酵素反応を停止するための反応停止剤等を
任意の組合せで包含させることができる。In addition to the essential components, the detection reagent of the present invention can contain various auxiliary agents to facilitate the use of the detection reagent. For example, a solubilizing agent to dissolve solids, a cleaning agent to remove unnecessary components during the reaction, a substrate to measure the enzyme activity if the standard substance is an enzyme, and a substance to stop the enzyme reaction. Reaction terminators and the like can be included in any combination.
[実施例コ
以下実施例及び比較例により本発明を更に説明するが本
発明はこれに限定されるものではない。[Example] The present invention will be further explained below with reference to Examples and Comparative Examples, but the present invention is not limited thereto.
実施例1 特定の核酸の検出
l)試料中の相補的な一本鎖核酸の調製市販のpBR3
22(宝酒造製)と制限酵素BglI(TOYOBO製
、 pBR322を3断片に切断する)とからメーカー
推薦の反応条件で完全消化し、フェノール抽出、エタノ
ール沈殿等の通常の操作を経て精製し、更に精製したも
のを100’C,10分で熱変性し、濃度を100μg
/mlに調整したものを核酸試薬(A)として以下の検
討に用いた。Example 1 Detection of specific nucleic acids l) Preparation of complementary single-stranded nucleic acids in samples Commercially available pBR3
22 (manufactured by Takara Shuzo) and the restriction enzyme BglI (manufactured by TOYOBO, which cuts pBR322 into 3 fragments) under the reaction conditions recommended by the manufacturer, purified through normal operations such as phenol extraction and ethanol precipitation, and further purified. The sample was heat denatured at 100'C for 10 minutes to give a concentration of 100 μg.
/ml was used as the nucleic acid reagent (A) in the following study.
2)固定化した一本鎖核酸の調製
一本鎖核酸は市販のpBR322PrlmerH(宝酒
造製、塩基数16でpBR322と相補な塩基配列をも
つ)を用いた。0.1Mの炭酸緩衝液(pH9,8)に
溶解した(1.1p g/ml−Pr1merl111
00μIをポリスチレン製の試験管に入れ、2時間室温
で振盪した。次に0.O1%Tveen含有0.02M
燐酸緩衝液(1)H7,5) (0,01%Twee
n−PH5)の500μIで2回洗浄し、PBSに溶解
した■%EISAを加え、37℃、10分加温振盪した
ものを固定化した一本鎖核酸試薬CB)として以下の検
出に用いた。2) Preparation of immobilized single-stranded nucleic acid As the single-stranded nucleic acid, commercially available pBR322PrlmerH (manufactured by Takara Shuzo Co., Ltd., has 16 bases and a complementary base sequence to pBR322) was used. (1.1 p g/ml-Pr1merl111 dissolved in 0.1 M carbonate buffer (pH 9,8)
00 μI was placed in a polystyrene test tube and shaken at room temperature for 2 hours. Then 0. Contains O1% Tveen 0.02M
Phosphate buffer (1) H7,5) (0,01% Twee
Washed twice with 500μI of n-PH5), added ■% EISA dissolved in PBS, heated and shaken at 37°C for 10 minutes, and used as immobilized single-stranded nucleic acid reagent CB) for the following detection. .
3)標識抗体の調製
市販の抗核酸抗体(ケミコン・インタ−ナシ3ナル社製
)を文献[ニス・ヨシタケ、エム・イマガワ、イー・イ
シカワ、エトール; ジェイ・バイオケム(S、YO5
ITAKE、M、1MAGAWA、E、l5IKAIr
A et al:J、Biocbem、)、vol、9
2(1982) 1413−1424コに記載の方法
によってペルオキシダーゼ(POD)と結合し、標識抗
体を得た。これを1%牛血清アルブミン(BSA)含有
緩衝液で10μg/mlに希釈したものを標識抗体試薬
(C)として以下に使用した。3) Preparation of labeled antibodies A commercially available anti-nucleic acid antibody (manufactured by Chemi-Con International) was prepared according to the literature [Nisu Yoshitake, M. Imagawa, E. Ishikawa, Etol; J. Biochem (S, YO5).
ITAKE, M, 1MAGAWA, E, l5IKAIr
A et al: J, Biocbem, ), vol. 9
2 (1982) 1413-1424 to obtain a labeled antibody. This was diluted to 10 μg/ml with a buffer containing 1% bovine serum albumin (BSA) and used as a labeled antibody reagent (C) below.
4)交雑
予め、95℃、5分で加熱し、直ちに氷上で冷却した(
A)の0.5.10及び20μlを含むPBS500μ
lと(B)とを混合し、60℃×2時間加温振盪で交雑
させ、次いで0.01%tveen−PBS (500
μIX2回)で洗浄した。4) Before hybridization, heat at 95°C for 5 minutes and immediately cool on ice (
500μl of PBS containing 0.5.10 and 20μl of A)
1 and (B) were mixed, heated and shaken at 60°C for 2 hours, and then hybridized with 0.01% tveen-PBS (500°C).
Washed with μIX (2 times).
5)酵素分解
市販のSlヌクレース(宝酒造製)をメーカー推薦のm
新液にて10unIts/ mlの濃度に調製したもの
を分解酵素試薬(D)として以下に使用した。この10
μmを含む上記緩衝液500μlを4)の反応物に添加
し、37°CXIG分反応した後4)と同様0,01%
tveen含有PBS(500μlXZ回)で洗浄した
。5) Enzymatically decomposed commercially available Sl Nuclease (manufactured by Takara Shuzo) as recommended by the manufacturer.
A fresh solution prepared at a concentration of 10 units/ml was used as the degrading enzyme reagent (D) below. These 10
Add 500 μl of the above buffer containing μm to the reaction product of 4), react for 37°CXIG minutes, and then add 0.01%
Washed with tveen-containing PBS (500 μl XZ times).
8)@出
5)で得た反応物に(C)を100μm及びPflS4
0Qμmを添加し、37°c x go分加温振盪した
後、生理食塩水にて洗浄した。これに基質溶液(過酸化
水素含有オルトフェニレンジアミン溶液)500μmを
加え、37”CX30分加温振盪した後、3mlの1.
5N硫酸で反応を停止した。この液の492nmの吸光
度を測定し、試験管に結合した酵素の活性を測定した。8) Add (C) to the reaction product obtained in step 5) at 100 μm and PflS4
After adding 0Qμm and shaking while heating at 37°C x go minutes, the mixture was washed with physiological saline. To this was added 500 μm of a substrate solution (hydrogen peroxide-containing orthophenylenediamine solution), and after heating and shaking in a 37”CX for 30 minutes, 3 ml of 1.
The reaction was stopped with 5N sulfuric acid. The absorbance of this liquid at 492 nm was measured to determine the activity of the enzyme bound to the test tube.
第一図に本検出法による核酸の検出結果を示した。Figure 1 shows the results of nucleic acid detection by this detection method.
比較例1
実施例1において交雑しなかった核酸を酵素で分解する
ことな〈実施する以外は実施例1と同様に行なって検出
した。Comparative Example 1 Detection was carried out in the same manner as in Example 1, except that the nucleic acids that did not hybridize in Example 1 were not decomposed with enzymes.
第一図に比較例1による検出結果を示した。FIG. 1 shows the detection results according to Comparative Example 1.
この結果酵素処理により一本鎖核酸と相補な核酸のみが
特異的、安全且つ迅速に検出されることがわかる。The results show that only nucleic acids complementary to single-stranded nucleic acids can be specifically, safely, and rapidly detected by enzyme treatment.
実施例2
本発明の検出試薬は以下の試薬を別々の容器に充填した
後密栓して製造した。Example 2 A detection reagent of the present invention was produced by filling the following reagents into separate containers and sealing the containers.
■)核酸試薬(A) 1.2m12
)固定化した一本鎖核酸試薬(B) 100本3)標
識抗体試薬(C) +211114)分
解酵素試薬(D) ■、211115)
分解酵素用緩衝液 &(1m18)PBS
120+a17)0.0
1%TveerrPBS 240m18
)生理食塩水 1000m19)基質
溶液 [10m110)硫酸(1
,5N) 350ml実施例3
複数の特定な核酸の検出
■)試料中の相補的な一本鎖核酸の調製市販の核酸pB
R322DNA及び旧3mp19RFDNA (いづれ
も宝酒造製)を各々制限酵素旧ndIn (宝酒造製)
でメーカー推薦の反応条件で完全消化し、フェノール抽
出、エタノール沈殿等の通常の操作を経て精製し、更に
精製したものを+00°C,10分で熱変性し、各試料
を混合し、最終的に夫々の濃度を1008g7m lに
調整したものを核酸試薬(E)として以下の検討に用い
た。■) Nucleic acid reagent (A) 1.2m12
) Immobilized single-stranded nucleic acid reagent (B) 100 pieces 3) Labeled antibody reagent (C) +211114) Degrading enzyme reagent (D) ■, 211115)
Degrading enzyme buffer & (1m18) PBS
120+a17)0.0
1%TveerrPBS 240m18
) Physiological saline 1000ml19) Substrate solution [10ml110) Sulfuric acid (1
, 5N) 350ml Example 3
Detection of multiple specific nucleic acids ■) Preparation of complementary single-stranded nucleic acids in a sample Commercially available nucleic acid pB
R322 DNA and old 3mp19RF DNA (both manufactured by Takara Shuzo) were treated with the restriction enzyme old ndIn (manufactured by Takara Shuzo).
Complete digestion under the reaction conditions recommended by the manufacturer, purification through normal operations such as phenol extraction and ethanol precipitation, further heat denaturation at +00°C for 10 minutes, mixing each sample, and final The respective concentrations were adjusted to 1008 g and 7 ml and used as the nucleic acid reagent (E) in the following study.
2)固定化した一本鎖核酸の調製
一本鎖核酸は市販のpBR322PrlmerB (宝
酒造製、塩基数18でpBR322と相補な塩基配列を
もつ)及び旧3Pr1merM3 (宝酒造製、塩基数
17で旧3vp19RFDNAと相補な塩基配列をもつ
)を用いた。0.1Mの炭酸緩衝液(pH9,8)に溶
解したそれぞれのPrimerを各0.1Ngets
Iになるよう混合し、その100μ!をポリスチレン製
の試験管に入れ、2時間室温で振盪した。2) Preparation of immobilized single-stranded nucleic acids The single-stranded nucleic acids were commercially available pBR322PrlmerB (manufactured by Takara Shuzo, with 18 bases and a complementary base sequence to pBR322) and old 3Pr1merM3 (manufactured by Takara Shuzo, with 17 bases and a complementary base sequence to pBR322). with complementary base sequences) was used. Gets 0.1 N of each primer dissolved in 0.1 M carbonate buffer (pH 9, 8).
Mix to make I, then 100μ! was placed in a polystyrene test tube and shaken at room temperature for 2 hours.
次に0.O1%Tveen含有0.02M燐酸緩衝液(
pH7,!li) (0,01%Tveen−P13
S)の500μlで2回洗浄し、 PBSに溶解した
1%BSAを加え、37℃、10分加温振盪したものを
固定化した一本鎖核酸試薬CF)として以下の検出に用
いた。Then 0. 0.02M phosphate buffer containing O1% Tveen (
pH7,! li) (0,01%Tveen-P13
The sample was washed twice with 500 μl of S), 1% BSA dissolved in PBS was added, and the mixture was heated and shaken at 37°C for 10 minutes, which was used as an immobilized single-stranded nucleic acid reagent CF) for the following detection.
又実施例1で使用した(B)も併用して用いた。In addition, (B) used in Example 1 was also used in combination.
3)標識抗体の調製 実施例1に同じ。3) Preparation of labeled antibody Same as Example 1.
4)交雑
予め、95℃、5分で加熱し、直ちに氷上で冷却した(
E)のQ、5.to及び20μlを含むPBS5(to
μlと(B)又は(F)とを混合し、60°CX2時間
加温振盪で交雑させ、次いで0.01%tveen−P
BS (500It l X 2回)で洗浄した。4) Before hybridization, heat at 95°C for 5 minutes and immediately cool on ice (
E) Q, 5. PBS5 (to
μl and (B) or (F) were mixed, heated and shaken at 60°C for 2 hours, and then mixed with 0.01% tveen-P.
Washed with BS (500 It l x 2).
5)酵素分解 実施例1に同じ。5) Enzyme degradation Same as Example 1.
6)検出 実施例1に同じ。6) Detection Same as Example 1.
第二図に本検出法による核酸の検出結果を示した。Figure 2 shows the results of nucleic acid detection using this detection method.
比較例2
実施例3において交雑しなかった核酸を酵素で分解する
ことな〈実施する以外は実施例3と同様に行なって検出
した。Comparative Example 2 Detection was carried out in the same manner as in Example 3, except that the nucleic acids that did not hybridize in Example 3 were not decomposed with enzymes.
第二図に比較例2による検出結果を示した。FIG. 2 shows the detection results according to Comparative Example 2.
この結果酵素処理により一本鎖核酸と相補な核酸のみが
特異的、安全且つ迅速に検出されることがわかる。The results show that only nucleic acids complementary to single-stranded nucleic acids can be specifically, safely, and rapidly detected by enzyme treatment.
実施例4
本発明の検出試薬は以下の試薬を別々の容器に充填した
後密栓して製造した。Example 4 A detection reagent of the present invention was produced by filling the following reagents into separate containers and then sealing the containers.
I)核酸試薬(E) 2.4m12
)固定化した一本鎖核酸試薬CF) +oo本3)固
定化した一本鎖核酸試薬(B) 100本4)標識抗
体試薬(C) 24m15)分解酵素試
薬(D) 2.4116)分解酵素用緩
衝液 1201117)PBS
240m+18)0.01%Tve
en−PBS 480m13)生理食塩
水 2000旧10)基質溶液
目)硫酸(1,5N)
20m1
00m1
実施例5 特定の核酸の検出
1)試料中の相補的な一本鎖核酸の調製実施例1に同じ
。I) Nucleic acid reagent (E) 2.4m12
) Immobilized single-stranded nucleic acid reagent CF) +oo books 3) Immobilized single-stranded nucleic acid reagent (B) 100 pieces 4) Labeled antibody reagent (C) 24m15) Degrading enzyme reagent (D) 2.4116) Degrading enzyme Buffer solution 1201117) PBS
240m+18)0.01%Tve
en-PBS 480ml 13) Physiological saline 2000 old 10) Substrate solution 1) Sulfuric acid (1,5N) 20ml 00ml Example 5 Detection of specific nucleic acid 1) Preparation of complementary single-stranded nucleic acid in sample In Example 1 same.
2)固定化した一本鎖核酸の調製
まず、一本鎖核酸は市販のpBR322PrlmerH
と同様の塩基配列を有するオリゴヌクレオチドの5′末
端ヒドロキシル基をカルボジイミダゾール及びヘキサメ
チレンジアミンにてアミノアルキルたものを入手した。2) Preparation of immobilized single-stranded nucleic acid First, single-stranded nucleic acid was prepared using commercially available pBR322PrlmerH.
An oligonucleotide having the same base sequence as the above was obtained by converting the 5'-terminal hydroxyl group to aminoalkyl using carbodiimidazole and hexamethylene diamine.
又、支持体としてはγーアミノプロブルシランにて予め
表面上をアミノ化処理した外径8m+++のスリガラス
ビーズを使用し、これとジサクシニミジルサブストレー
) (DSS)及び上記のアミノアルキル化ヌクレオチ
ドを混合し、室温、24時間反応させた。次にこの反応
物のヌクレオチド濃度を0.1Ng/mlに調節し、実
施例1間・様の処理をしたものを固定化した一本鎖核酸
試薬(G)とし、以下の検出に用いた。In addition, as a support, ground glass beads with an outer diameter of 8 m+++ whose surface had been aminated in advance with γ-aminoproblesilane were used, and this and disuccinimidyl substrate (DSS) and the above aminoalkylated The nucleotides were mixed and allowed to react at room temperature for 24 hours. Next, the nucleotide concentration of this reaction product was adjusted to 0.1 Ng/ml and treated as in Example 1 to obtain an immobilized single-stranded nucleic acid reagent (G), which was used for the following detection.
3)標識抗体の調製 実施例1と同じ。3) Preparation of labeled antibody Same as Example 1.
4)交雑
予め、95°C,5分で加熱し、直ちに氷上で冷却した
(^)の0.5.10及び20μlを含むPBS500
μlと(G)とを混合し、60°CX2時間加温振盪で
交雑させ、次b)で0.01%tween−PBS (
500μlXZ回)で洗浄した。4) PBS500 containing 0.5.10 and 20 μl of (^) heated at 95°C for 5 minutes and immediately cooled on ice before hybridization.
μl and (G) were mixed, heated and shaken at 60°C for 2 hours, and then b) was added with 0.01% tween-PBS (
Washed with 500 μl x Z times).
5)酵素分解 実施例1と同じ。5) Enzyme degradation Same as Example 1.
6)検出 実施例1と同じ。6) Detection Same as Example 1.
第三図に本検出法による核酸の検出結果を示した。Figure 3 shows the results of nucleic acid detection by this detection method.
比較例3
実施例5において交雑しなかった核酸を酵素で分解する
ことな〈実施する以外は実施例5と同様に行なって検出
した。Comparative Example 3 Detection was carried out in the same manner as in Example 5, except that the nucleic acids that did not hybridize in Example 5 were not decomposed with enzymes.
第三図に比較例3による検出結果を示した。Figure 3 shows the detection results according to Comparative Example 3.
この結果支持体及び一本鎖核酸間に一定の分子長がある
ことで感度良く、且つ酵素処理により一本鎖核酸と相補
な核酸のみが特異的、安全且つ迅速に検出されることが
わかる。The results show that the presence of a certain molecular length between the support and the single-stranded nucleic acid provides good sensitivity, and that only nucleic acids complementary to the single-stranded nucleic acid can be detected specifically, safely, and quickly by enzyme treatment.
実施例6
本発明の検出試薬は以下の試薬を別々の容器に充填した
後密栓して製造した。Example 6 A detection reagent of the present invention was produced by filling the following reagents into separate containers and then sealing the containers.
l)核酸試薬(A) 1.2m12
)固定化した一本鎖核酸試薬(c) too本3)標
識抗体試薬(C) 12m14)分解酵
素試薬(D) 1.2m15)分解酵素
用緩衝液 Hml[1)PBS
120m17)0.01%Twee
n−PBS 240m18)生理食塩水
1000m19〉基質溶液
60m110)硫酸(1,5N)
350+111[発明の効果コ
本発明の検出法及び検出試薬によれば、従来の検出法に
比べ特異性が高く、迅速で且つ安全な測定が可能となる
。l) Nucleic acid reagent (A) 1.2m12
) Immobilized single-stranded nucleic acid reagent (c) too much 3) Labeled antibody reagent (C) 12m14) Degrading enzyme reagent (D) 1.2m15) Degrading enzyme buffer Hml [1] PBS
120m17) 0.01%Twee
n-PBS 240ml 18) Physiological saline 1000ml 19> Substrate solution
60ml110) Sulfuric acid (1,5N)
350+111 [Effects of the Invention] The detection method and detection reagent of the present invention have higher specificity than conventional detection methods, and enable rapid and safe measurements.
従来の検出法においては対象とする核酸を固定し、−本
鎖核酸を32pのような放射性同位元素を標識物質とし
て用いる場合、検出感度としては大変高感度であるが、
操作上の手間及び安全性の点では問題が多い。また抗体
を用いた検出法では、核酸の免疫原性が弱いため、交雑
した核酸に対する特異的な抗体が得られ難く、検出精度
が悪くなる。本発明はこれらの欠点を大きく改良するた
めの方法を提供するものである。In conventional detection methods, when the target nucleic acid is immobilized and a radioactive isotope such as 32p is used as a labeling substance for the double-stranded nucleic acid, the detection sensitivity is very high;
There are many problems in terms of operational effort and safety. Furthermore, in detection methods using antibodies, since the immunogenicity of nucleic acids is weak, it is difficult to obtain antibodies specific to hybridized nucleic acids, resulting in poor detection accuracy. The present invention provides a method for significantly overcoming these drawbacks.
また−本鎖核酸を複数使用する場合には変異株を持つウ
ィルスや細菌を同一検査試薬で測定できることや、多種
の疾病の同時検出を可能にした点が特徴である。一般に
ウィルスや細菌は種々の外的要因により容易に変異株を
形成し、しばしばその診断・治療を困難にする。例えば
パピローマウィルス或はインフルエンザウィルスは多種
の変異株を有し、後者は特に毎年その株種を替え、流行
する。従って一種の核酸しか検出出来ない試薬の場合、
その診断を誤ることにも成りかねない。本発明の検査法
によるとこの誤りを無くすことができ、マススクリーニ
ングに大変都合がよい。Furthermore, when multiple single-stranded nucleic acids are used, viruses and bacteria with mutant strains can be measured with the same test reagent, and a variety of diseases can be detected simultaneously. In general, viruses and bacteria easily form mutant strains due to various external factors, which often makes diagnosis and treatment difficult. For example, papillomaviruses and influenza viruses have many mutant strains, and the latter in particular changes its strain type every year and becomes prevalent. Therefore, in the case of a reagent that can only detect one type of nucleic acid,
It may also lead to incorrect diagnosis. The testing method of the present invention can eliminate this error and is very convenient for mass screening.
以上の点から本発明は特に高感度、高精度の測定が要求
される血清またはその他の体液中に極微量存在する目的
の核酸又は食品中の生物汚染に由来する核酸を特異的に
検出でき、且つこれらの検出時間を著しく短縮できるも
のである。本発明の主用途である臨床検査及び食品製造
への適用にはこの点特に好ましい。In view of the above, the present invention can specifically detect target nucleic acids present in extremely small amounts in serum or other body fluids, which require highly sensitive and highly accurate measurements, or nucleic acids derived from biological contamination in foods. Moreover, the detection time can be significantly shortened. This is particularly preferred for application to clinical testing and food production, which are the main uses of the present invention.
第一図は実施例1及び比較例1の核酸の検出結果を、第
二図は実施例3及び比較例2の核酸の検出結果を、第三
図は実施例5及び比較例3の核酸の検出結果を夫々示し
たグラフである。
図面
策−図
(A)μl
第二図
ローロ ;
比較例2で(B)を用いた場合Figure 1 shows the detection results of nucleic acids in Example 1 and Comparative Example 1, Figure 2 shows the detection results of nucleic acids in Example 3 and Comparative Example 2, and Figure 3 shows the detection results of nucleic acids in Example 5 and Comparative Example 3. It is a graph showing each detection result. Drawing strategy - Figure (A) μl Figure 2 Rollo; When (B) is used in Comparative Example 2
Claims (1)
し、特定の核酸を検出する方法において、交雑しなかっ
た一本鎖核酸を除去し、交雑して二本鎖となった核酸を
、標準物質で標識された結合性物質で検出することを特
徴とする核酸の検出法。 2、除去を分解によって行う請求項1記載の検出法。 3、分解を酵素を用いて行なう請求項2記載の検出法。 4、酵素が一本鎖核酸に特異的に作用する酵素である請
求項3記載の検出法。 5、一本鎖核酸が支持体に固定されている請求項1〜4
項のいずれか記載の検出法。 6、一本鎖核酸が化学的方法で合成された核酸である請
求項1〜5項のいずれか記載の検出法。 7、結合性物質が蛋白である請求項1〜6項のいずれか
記載の検出法。 8、蛋白が抗体である請求項7記載の検出法。 9、標識物質が酵素である請求項1〜8項のいずれか記
載の検出法。 10、交雑しなかった一本鎖核酸を除去する物質及び交
雑して二本鎖となった核酸と反応する、標識物質で標識
された結合性物質を含有してなる請求項1〜9項のいず
れか記載の検出法に使用される核酸の検出試薬。[Claims] 1. A method for detecting a specific nucleic acid by hybridizing a single-stranded nucleic acid with a complementary single-stranded nucleic acid in a sample, in which the uncrossed single-stranded nucleic acid is removed and the hybridization is performed. A method for detecting nucleic acids, which comprises detecting double-stranded nucleic acids using a binding substance labeled with a standard substance. 2. The detection method according to claim 1, wherein the removal is carried out by decomposition. 3. The detection method according to claim 2, wherein the decomposition is carried out using an enzyme. 4. The detection method according to claim 3, wherein the enzyme is an enzyme that specifically acts on single-stranded nucleic acids. 5. Claims 1 to 4, wherein the single-stranded nucleic acid is immobilized on a support.
Detection method described in any of paragraphs. 6. The detection method according to any one of claims 1 to 5, wherein the single-stranded nucleic acid is a nucleic acid synthesized by a chemical method. 7. The detection method according to any one of claims 1 to 6, wherein the binding substance is a protein. 8. The detection method according to claim 7, wherein the protein is an antibody. 9. The detection method according to any one of claims 1 to 8, wherein the labeling substance is an enzyme. 10. Claims 1 to 9 containing a substance that removes single-stranded nucleic acids that have not hybridized and a binding substance that is labeled with a labeling substance that reacts with the hybridized double-stranded nucleic acids. A nucleic acid detection reagent used in any of the detection methods described above.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19900112479 EP0405592A3 (en) | 1989-06-30 | 1990-06-29 | A method for detection of nucleic acid and reagents for their detection |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1-170685 | 1989-06-30 | ||
JP17068589 | 1989-06-30 | ||
JP19313089 | 1989-07-26 | ||
JP1-193130 | 1989-07-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03130097A true JPH03130097A (en) | 1991-06-03 |
Family
ID=26493610
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22377389A Pending JPH03130097A (en) | 1989-06-30 | 1989-08-30 | Detection of nucleic acid and detection reagent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03130097A (en) |
-
1989
- 1989-08-30 JP JP22377389A patent/JPH03130097A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1272443A (en) | Solution-phase dual hybridization assay for detecting polynucleotide sequences | |
US5200313A (en) | Nucleic acid hybridization assay employing detectable anti-hybrid antibodies | |
EP0439222B1 (en) | Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and purification methods | |
CA1338207C (en) | Method of assaying of nucleic acids, a reagent combination and kit therefore | |
EP0235726B1 (en) | Rapid detection of nucleic acid sequences in a sample by labeling the sample | |
EP0336454B1 (en) | Nucleic acid hybridization assay | |
EP0219695B1 (en) | Immobilization of nucleic acids in solvolyzed nylon supports | |
EP0147665A1 (en) | Nucleic acid probe, test method and reagent system for detecting a polynucleotide sequence and antibody therefor | |
JPH0740960B2 (en) | Nucleic acid detection kit | |
JPS60144662A (en) | Nucleic acid probe, polynucleotide alignment and testing method and reagent group for detecting antibody thereof | |
JPH10508741A (en) | Amplification method for increasing sensitivity of nucleic acid-probe target hybrid detection | |
JP2690738B2 (en) | Nucleic acid detection method and device | |
EP0530998B1 (en) | Detection of complementary nucleotide sequences | |
JPH08501689A (en) | Improved Strand Displacement Assay and Complexes Useful Therefor | |
JP2000502894A (en) | Homogeneous DNA probe titration assay | |
EP0146815A2 (en) | Nucleic acid hybridization assay employing antibodies to intercalation complexes | |
JPH08501220A (en) | Isolated nucleotide sequence for identification of Neisseria gonorrhoeae | |
JPH01501339A (en) | Improved nucleic acid hybridization method and kit used therefor | |
Vary | Triple-helical capture assay for quantification of polymerase chain reaction products | |
JPH03130097A (en) | Detection of nucleic acid and detection reagent | |
JPH0670799A (en) | Hybridization method | |
JPH03130098A (en) | Detection of nucleic acid and detection reagent | |
JPH03128000A (en) | Method and agent for detecting nucleic acid | |
JPH11142409A (en) | Detection method of pathogenic microbe | |
EP0401313B1 (en) | Macromolecular conjugate |